These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
142 related articles for article (PubMed ID: 17008470)
1. Administration of vascular endothelial growth factor Trap during the 'post-angiogenic' period of the luteal phase causes rapid functional luteolysis and selective endothelial cell death in the marmoset. Fraser HM; Wilson H; Wulff C; Rudge JS; Wiegand SJ Reproduction; 2006 Oct; 132(4):589-600. PubMed ID: 17008470 [TBL] [Abstract][Full Text] [Related]
2. Effects of inhibition of vascular endothelial growth factor at time of selection on follicular angiogenesis, expansion, development and atresia in the marmoset. Taylor PD; Wilson H; Hillier SG; Wiegand SJ; Fraser HM Mol Hum Reprod; 2007 Oct; 13(10):729-36. PubMed ID: 17804434 [TBL] [Abstract][Full Text] [Related]
3. Luteal angiogenesis: prevention and intervention by treatment with vascular endothelial growth factor trap(A40). Wulff C; Wilson H; Rudge JS; Wiegand SJ; Lunn SF; Fraser HM J Clin Endocrinol Metab; 2001 Jul; 86(7):3377-86. PubMed ID: 11443214 [TBL] [Abstract][Full Text] [Related]
4. Inhibition of delta-like ligand 4 induces luteal hypervascularization followed by functional and structural luteolysis in the primate ovary. Fraser HM; Hastings JM; Allan D; Morris KD; Rudge JS; Wiegand SJ Endocrinology; 2012 Apr; 153(4):1972-83. PubMed ID: 22334711 [TBL] [Abstract][Full Text] [Related]
5. Suppression of luteal angiogenesis in the primate after neutralization of vascular endothelial growth factor. Fraser HM; Dickson SE; Lunn SF; Wulff C; Morris KD; Carroll VA; Bicknell R Endocrinology; 2000 Mar; 141(3):995-1000. PubMed ID: 10698175 [TBL] [Abstract][Full Text] [Related]
6. Angiogenesis and vascular endothelial growth factor expression in the equine corpus luteum. Al-zi'abi MO; Watson ED; Fraser HM Reproduction; 2003 Feb; 125(2):259-70. PubMed ID: 12578540 [TBL] [Abstract][Full Text] [Related]
7. Angiogenesis in the corpus luteum of early pregnancy in the marmoset and the effects of vascular endothelial growth factor immunoneutralization on establishment of pregnancy. Rowe AJ; Morris KD; Bicknell R; Fraser HM Biol Reprod; 2002 Oct; 67(4):1180-8. PubMed ID: 12297534 [TBL] [Abstract][Full Text] [Related]
8. Vascular composition, apoptosis, and expression of angiogenic factors in the corpus luteum during prostaglandin F2alpha-induced regression in sheep. Vonnahme KA; Redmer DA; Borowczyk E; Bilski JJ; Luther JS; Johnson ML; Reynolds LP; Grazul-Bilska AT Reproduction; 2006 Jun; 131(6):1115-26. PubMed ID: 16735551 [TBL] [Abstract][Full Text] [Related]
9. Mid-luteal angiogenesis and function in the primate is dependent on vascular endothelial growth factor. Dickson SE; Bicknell R; Fraser HM J Endocrinol; 2001 Mar; 168(3):409-16. PubMed ID: 11241172 [TBL] [Abstract][Full Text] [Related]
10. Cell proliferation and vascular morphology in the marmoset corpus luteum. Young FM; Rodger FE; Illingworth PJ; Fraser HM Hum Reprod; 2000 Mar; 15(3):557-66. PubMed ID: 10686196 [TBL] [Abstract][Full Text] [Related]
12. Insulin-like growth factor binding protein-3 mRNA expression in endothelial cells of the primate corpus luteum. Fraser HM; Lunn SF; Kim H; Erickson GF Hum Reprod; 1998 Aug; 13(8):2180-5. PubMed ID: 9756293 [TBL] [Abstract][Full Text] [Related]
13. Inhibition of vascular endothelial growth factor in the primate ovary up-regulates hypoxia-inducible factor-1alpha in the follicle and corpus luteum. Duncan WC; van den Driesche S; Fraser HM Endocrinology; 2008 Jul; 149(7):3313-20. PubMed ID: 18388198 [TBL] [Abstract][Full Text] [Related]
14. Vascular endothelial growth factor Trap suppresses ovarian function at all stages of the luteal phase in the macaque. Fraser HM; Wilson H; Morris KD; Swanston I; Wiegand SJ J Clin Endocrinol Metab; 2005 Oct; 90(10):5811-8. PubMed ID: 16046580 [TBL] [Abstract][Full Text] [Related]
15. Temporal relationship between proliferating and apoptotic hormone-producing and endothelial cells in the equine corpus luteum. Aguilar J; Fraser HM; Wilson H; Clutton E; Shaw DJ; Watson ED Reproduction; 2006 Jul; 132(1):111-8. PubMed ID: 16816337 [TBL] [Abstract][Full Text] [Related]
16. Inhibition of early luteal angiogenesis by gonadotropin-releasing hormone antagonist treatment in the primate. Dickson SE; Fraser HM J Clin Endocrinol Metab; 2000 Jun; 85(6):2339-44. PubMed ID: 10852474 [TBL] [Abstract][Full Text] [Related]
17. Endocrine and cellular characteristics of corpora lutea from cows with a delayed post-ovulatory progesterone rise. Robinson RS; Hammond AJ; Nicklin LT; Schams D; Mann GE; Hunter MG Domest Anim Endocrinol; 2006 Aug; 31(2):154-72. PubMed ID: 16289469 [TBL] [Abstract][Full Text] [Related]
18. Immunoexpression of vascular endothelial growth factor and vWF-regulating angiogenesis in cyclic corpus luteum of Indian buffalo. Kapoor K; Singh O; Pathak D; Sethi RS Anat Histol Embryol; 2024 Jan; 53(1):e13001. PubMed ID: 37988190 [TBL] [Abstract][Full Text] [Related]
19. Angiogenesis in the human corpus luteum: localization and changes in angiopoietins, tie-2, and vascular endothelial growth factor messenger ribonucleic acid. Wulff C; Wilson H; Largue P; Duncan WC; Armstrong DG; Fraser HM J Clin Endocrinol Metab; 2000 Nov; 85(11):4302-9. PubMed ID: 11095472 [TBL] [Abstract][Full Text] [Related]
20. Cyclic changes in expression of mRNA of vascular endothelial growth factor, its receptors Flt-1 and KDR/Flk-1, and Ets-1 in human corpora lutea. Endo T; Kitajima Y; Nishikawa A; Manase K; Shibuya M; Kudo R Fertil Steril; 2001 Oct; 76(4):762-8. PubMed ID: 11591411 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]